comparemela.com

Latest Breaking News On - Kyle yang - Page 1 : comparemela.com

Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer - Fusion Pharmaceuticals (NASDAQ:FUSN)

Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), citing the company's pipeline as among the best in the space with alpha-emitter-based targeted radionuclide therapies (TRTs), with three currently in clinical development.

Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer

Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc FUSN, citing the company's pipeline as among the best in the space with alpha-emitter-based…

Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer - Corvus Pharma (NASDAQ:CRVS)

Oppenheimer has initiated coverage on Corvus Pharmaceuticals Inc (NASDAQ: CRVS) with an Outperform rating and a 

Heybike unveils Ranger S e-Bike with longer battery life, and mileage, and a truly affordable price

/PRNewswire/ Following the success of its Ranger e-Bike launch last year, Heybike® has unveiled its upgraded, most advanced e-Bike model yet, the Ranger S..

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.